Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
27 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Oncolys BioPharma Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Oncolys BioPharma Inc. - Product Pipeline Review - 2014', provides an overview of the Oncolys BioPharma Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Oncolys BioPharma Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Oncolys BioPharma Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Oncolys BioPharma Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Oncolys BioPharma Inc.'s pipeline products Reasons to buy - Evaluate Oncolys BioPharma Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Oncolys BioPharma Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Oncolys BioPharma Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Oncolys BioPharma Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Oncolys BioPharma Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Oncolys BioPharma Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Oncolys BioPharma Inc. Snapshot 5 Oncolys BioPharma Inc. Overview 5 Key Information 5 Key Facts 5 Oncolys BioPharma Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Oncolys BioPharma Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 Oncolys BioPharma Inc. - Pipeline Products Glance 12 Oncolys BioPharma Inc. - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 Oncolys BioPharma Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Oncolys BioPharma Inc. - Drug Profiles 15 OBP-301 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 OBP-801 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 OBPAI-001 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 OBPAI-002 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Oncolys BioPharma Inc. - Pipeline Analysis 19 Oncolys BioPharma Inc. - Pipeline Products by Target 19 Oncolys BioPharma Inc. - Pipeline Products by Route of Administration 20 Oncolys BioPharma Inc. - Pipeline Products by Molecule Type 21 Oncolys BioPharma Inc. - Pipeline Products by Mechanism of Action 22 Oncolys BioPharma Inc. - Recent Pipeline Updates 23 Oncolys BioPharma Inc. - Dormant Projects 24 Oncolys BioPharma Inc. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Appendix 26 Methodology 26 Coverage 26 Secondary Research 26 Primary Research 26 Expert Panel Validation 26 Contact Us 27 Disclaimer 27
List of Tables Oncolys BioPharma Inc., Key Information 5 Oncolys BioPharma Inc., Key Facts 5 Oncolys BioPharma Inc. - Pipeline by Indication, 2014 7 Oncolys BioPharma Inc. - Pipeline by Stage of Development, 2014 8 Oncolys BioPharma Inc. - Monotherapy Products in Pipeline, 2014 9 Oncolys BioPharma Inc. - Out-Licensed Products in Pipeline, 2014 10 Oncolys BioPharma Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 11 Oncolys BioPharma Inc. - Phase I, 2014 12 Oncolys BioPharma Inc. - Preclinical, 2014 13 Oncolys BioPharma Inc. - Discovery, 2014 14 Oncolys BioPharma Inc. - Pipeline by Target, 2014 19 Oncolys BioPharma Inc. - Pipeline by Route of Administration, 2014 20 Oncolys BioPharma Inc. - Pipeline by Molecule Type, 2014 21 Oncolys BioPharma Inc. - Pipeline Products by Mechanism of Action, 2014 22 Oncolys BioPharma Inc. - Recent Pipeline Updates, 2014 23 Oncolys BioPharma Inc. - Dormant Developmental Projects,2014 24 Oncolys BioPharma Inc., Other Locations 25
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.